Ariad Pharmaceuticals Aktie [WKN: 895301 / ISIN: US04033A1007]

Sende E-Mail

Analysen zur Ariad Pharmaceuticals Inc.

17.12.2007Ariad Pharmaceuticals buyJefferies & Company Inc.plus
28.11.2007Ariad Pharmaceuticals DowngradeJP Morgan Chase & Co.neutal
12.02.2007Update Ariad Pharmaceuticals Inc.: OverweightJP Morganplus
02.05.2006Ariad Pharmaceuticals DowngradeBanc of America Sec.neutal
09.12.2005Ariad Pharma. ErsteinschätzungJP Morganneutal
08.12.2005Update Ariad Pharmaceuticals Inc.: NeutralJP Morganneutal
14.11.2005Ariad Pharmaceuticals outperformLeerink Swannplus
11.07.2005Ariad Pharmaceuticals buyBanc of America Sec.plus
08.07.2005Update Ariad Pharmaceuticals Inc.: BuyBanc of America Sec.plus
28.06.2005Update Ariad Pharmaceuticals Inc.: BuyOppenheimerplus
28.06.2005Ariad Pharmaceuticals buyOppenheimerplus
27.06.2005Update Ariad Pharmaceuticals Inc.: OutperformBear Stearnsplus
14.04.2005Update Ariad Pharmaceuticals Inc.: BuyAdams, Harkness & Hillplus
03.02.2005Update Ariad Pharmaceuticals Inc.: BuyLazard Freresplus




Wie bewerten Sie diese Seite?   sehr gut        schlecht
 

Anzeige